Stock Earnings Estimates Under Consideration: AK Steel Holding Corporation (NYSE:AKS)

The shares of AK Steel Holding Corporation (NYSE:AKS)currently has mean rating of 3.0 while 4 analyst have recommended the shares as ‘BUY’ ,0 recommended as ‘OUTPERFORM’ and 8 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of AK Steel Holding Corporation (NYSE:AKS)is at $4.58 while the highest price target suggested by the analysts is $7.00 and low price target is $2.00. The mean price target is calculated keeping in view the consensus of 12 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 1.53B by 9 analysts. The means estimate of sales for the year ending Dec 16 is 6.19B by 13 analysts.

The average estimate of EPS for the current fiscal quarter for AK Steel Holding Corporation (NYSE:AKS)stands at $-0.04 while the EPS for the current year is fixed at $0.13 by 14.00 analysts

The next one year’s EPS estimate is set at 0.39 by 15.00 analysts while a year ago the analysts suggested the company’s EPS at $0.13. The analysts also projected the company’s long-term growth at -11.78% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , AK Steel Holding Corporation (NYSE:AKS)reported earnings of $-0.08. The posted earnings topped the analyst’s consensus by $0.02 with the surprise factor of 20.00%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

AK Steel Holding Corporation (NYSE:AKS) traded up +2.10% during trading on Friday, hitting $4.94 . The stock had a trading volume of 7.8 M shares. The firm has a 50 day moving average of $4.24 and a 200-day moving average of $3.42. The stock has a market cap of $868.66M. On Jun 8, 2016 the shares registered one year high at $5.50 and the one year low was seen on Jan 20, 2016.

On June 21, 2016 AK Steel Holding Corporation (NYSE:AKS) said that it will increase base prices for all specialty sheet and strip stainless steel products by 3%-6%, effective July 5, 2016.

AK Steel

AK Steel is a world leader in the production of flat-rolled carbon, stainless and electrical steel products, primarily for automotive, infrastructure and manufacturing, construction and electrical power generation and distribution markets. Headquartered in West Chester, Ohio (Greater Cincinnati), the company employs approximately 8,500 men and women at eight steel plants, two coke plants and two tube manufacturing plants across six states: Indiana, Kentucky, Michigan, Ohio, Pennsylvania and West Virginia. Additional information about AK Steel is available at www.aksteel.com.

Noticeable Stock: Cemex SAB de CV (ADR) (NYSE:CX)

The shares of Cemex SAB de CV (ADR) (NYSE:CX)currently has mean rating of 2.1 while 11 analyst have recommended the shares as ‘BUY’ ,3 recommended as ‘OUTPERFORM’ and 4 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Cemex SAB de CV (ADR) (NYSE:CX)is at $8.76 while the highest price target suggested by the analysts is $15.87 and low price target is $6.73. The mean price target is calculated keeping in view the consensus of 18 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 3.77B by 3 analysts. The means estimate of sales for the year ending Dec 16 is 14.34B by 17 analysts.

The average estimate of EPS for the current fiscal quarter for Cemex SAB de CV (ADR) (NYSE:CX)stands at $0.07 while the EPS for the current year is fixed at $0.18 by 6.00 analysts

The next one year’s EPS estimate is set at 0.35 by 16.00 analysts while a year ago the analysts suggested the company’s EPS at $0.18. The analysts also projected the company’s long-term growth at 114.43% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Cemex SAB de CV (ADR) (NYSE:CX)reported earnings of $0.03. The posted earnings topped the analyst’s consensus by $0.07 with the surprise factor of 175.00%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Cemex SAB de CV (ADR) (NYSE:CX) traded up +4.29% during trading on Friday, hitting $6.80 . The stock had a trading volume of 7.7 M shares. The firm has a 50 day moving average of $6.51 and a 200-day moving average of $5.82. The stock has a market cap of $71.74B and a price-to-earnings ratio of 425.00. On Jun 26, 2015 the shares registered one year high at $9.22 and the one year low was seen on Jan 20, 2016.

On June 23, 2016 Cemex SAB de CV (ADR) (NYSE:CX) announced that CEMEX USA is participating in Phase 1 of the Metro Purple Line Extension in Los Angeles, California. This long-awaited extension will improve the Los Angeles public transportation system by linking the west part of the city to the region’s growing rail network. For this project, CEMEX is expected to supply at least 330,000 cubic yards of ready-mix concrete.

Phase 1 will provide high-speed, reliable transportation between popular areas of the city. Expected to be completed in 2023, the extension will comprise a 3.9-mile section of twin-rail subway, plus three underground stations in Los Angeles and Beverly Hills.

Project planning began in 2007 to ensure the completed development of this comprehensive project with the least possible impact on area residents. CEMEX was chosen for this project thanks to the expertise it demonstrated 10 years ago on the LA Metro Gold Line expansion.

“This project will improve transportation and mobility for generations of Los Angeles residents, and CEMEX enjoys the resources and experience to help make it a reality. We are proud to play an important role in building a better future for one of the USA’s greatest cities through the extension of the Metro Purple Line,” said Ignacio Madridejos, President CEMEX USA.

CEMEX is a global building materials company that provides high quality products and reliable service to customers and communities in more than 50 countries. Celebrating its 110th anniversary, CEMEX has a rich history of improving the well-being of those it serves through innovative building solutions, efficiency advancements, and efforts to promote a sustainable future.

Stock Earnings Estimates Under Consideration: U.S. Bancorp (NYSE:USB)

The shares of U.S. Bancorp (NYSE:USB)currently has mean rating of 2.6 while 10 analyst have recommended the shares as ‘BUY’ ,2 recommended as ‘OUTPERFORM’ and 20 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of U.S. Bancorp (NYSE:USB)is at $45.46 while the highest price target suggested by the analysts is $51.00 and low price target is $40.00. The mean price target is calculated keeping in view the consensus of 27 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 5.20B by 23 analysts. The means estimate of sales for the year ending Dec 16 is 20.90B by 26 analysts.

The average estimate of EPS for the current fiscal quarter for U.S. Bancorp (NYSE:USB)stands at $0.81 while the EPS for the current year is fixed at $3.27 by 30.00 analysts

The next one year’s EPS estimate is set at 3.52 by 32.00 analysts while a year ago the analysts suggested the company’s EPS at $3.27. The analysts also projected the company’s long-term growth at 4.87% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , U.S. Bancorp (NYSE:USB)reported earnings of $0.76. The posted earnings missed the analyst’s consensus by $0.00 with the surprise factor of 0.00%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

U.S. Bancorp (NYSE:USB) traded up +2.13% during trading on Friday, hitting $42.24 . The stock had a trading volume of 7.4 M shares. The firm has a 50 day moving average of $41.94 and a 200-day moving average of $41.14. The stock has a market cap of $72.91B and a price-to-earnings ratio of 13.36. On Jul 16, 2015 the shares registered one year high at $46.26 and the one year low was seen on Feb 11, 2016.

On June 23, 2016 Under Consideration: U.S. Bancorp (NYSE:USB) disclosed a summary of its Dodd-Frank Act Stress Test (“DFAST”) results. The disclosure includes the Company’s projected stressed minimum and end-of-period capital ratios for the period from the first quarter of 2016 through the first quarter of 2018. The projections assume annual common stock dividends equal to the quarterly average dollar amount of common stock dividends that the Company paid in the previous year and no redemption or repurchase of any capital instrument, in addition to estimates of losses, revenues, net income before taxes and loan losses by type of loan over the same time period. The projections were made under the “supervisory severely adverse scenario” defined by the Federal Reserve. This hypothetical stressed economic scenario is designed to assess the overall strength and resilience of the banking industry and does not necessarily represent future economic conditions expected by the Company.

A summary of the Company’s DFAST results are included in the table below. The Company’s DFAST results may differ from those calculated and published by the Federal Reserve due to differences in models, methodologies and tax rate, among other things. A document summarizing the risks and methodologies used to calculate the results, as well as an analysis of the significant reasons for the changes in capital ratios under the hypothetical stressed economic scenario is available on the Company’s website. The results can be found at: http://phx.corporate-ir.net/phoenix.zhtml?c=117565&p=irol-doddfrank

Earnings Estimates Under Spotlight: Procter & Gamble Co (NYSE:PG)

The shares of Procter & Gamble Co (NYSE:PG)currently has mean rating of 2.4 while 5 analyst have recommended the shares as ‘BUY’ ,6 recommended as ‘OUTPERFORM’ and 11 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Procter & Gamble Co (NYSE:PG)is at $85.30 while the highest price target suggested by the analysts is $95.00 and low price target is $74.00. The mean price target is calculated keeping in view the consensus of 20 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 15.84B by 18 analysts. The means estimate of sales for the year ending Jun 16 is 65.07B by 22 analysts.

The average estimate of EPS for the current fiscal quarter for Procter & Gamble Co (NYSE:PG)stands at $0.74 while the EPS for the current year is fixed at $3.64 by 21.00 analysts

The next one year’s EPS estimate is set at 3.97 by 24.00 analysts while a year ago the analysts suggested the company’s EPS at $3.64. The analysts also projected the company’s long-term growth at 6.13% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Procter & Gamble Co (NYSE:PG)reported earnings of $0.86. The posted earnings topped the analyst’s consensus by $0.04 with the surprise factor of 4.90%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Procter & Gamble Co (NYSE:PG) traded up +0.77% during trading on Friday, hitting $84.21 . The stock had a trading volume of 7.4 M shares. The firm has a 50 day moving average of $81.99 and a 200-day moving average of $80.98. The stock has a market cap of $224.15B and a price-to-earnings ratio of 26.54. On Jun 23, 2016 the shares registered one year high at $84.21 and the one year low was seen on Aug 24, 2015.

On June 16, 2016 Procter & Gamble Co (NYSE:PG) Van Tran from Brooklyn, NY was named the winner of the 12th Annual Toilet Paper Wedding Dress Contest presented by Cheap Chic Weddings and Charmin at design showcase.

Earlier, 10 finalists showcased their work at the contest’s finale event held at Haven Rooftop at The Sanctuary Hotel. Contestants crafted dresses out of nothing more than Charmin toilet paper, tape, glue and/or needle and thread, and this year, more than 1,500 entrants were up to the challenge. Members from Cheap Chic Weddings, Charmin, Edward Meyer of Ripley’s Believe it or Not, The Sanctuary’s Hank Freid and Michael Russo, event planner to the stars and member of OK! TV entertaining team, served as judges for this year’s contest. All were in attendance to help select the winning designs.

“All of the dresses deserve to be worn by a bride on her wedding day,” says Michael Russo. “Every single beautiful creation, with the incredible level of detail and the uniqueness of the design, is showroom and runway ready.”

Cheap-Chic-Weddings.com, an online company specializing in fiscally savvy tips for a fabulous wedding, launched the annual contest based on the popular bridal shower game. As the contest has gained notoriety, so has the level of competition.

“Even after 12 years, our designers still manage to challenge our expectations,” says Laura Gawne, co-founder of Cheap Chic Weddings. “They genuinely surprise us and make choosing a winner more and more difficult,” added co-founder Susan Bain.

Earnings Estimates Under Spotlight: Host Hotels and Resorts Inc (NYSE:HST)

The shares of Host Hotels and Resorts Inc (NYSE:HST)currently has mean rating of 2.5 while 4 analyst have recommended the shares as ‘BUY’ ,4 recommended as ‘OUTPERFORM’ and 11 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Host Hotels and Resorts Inc (NYSE:HST)is at $16.64 while the highest price target suggested by the analysts is $19.00 and low price target is $11.50. The mean price target is calculated keeping in view the consensus of 18 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 1.47B by 16 analysts. The means estimate of sales for the year ending Dec 16 is 5.46B by 17 analysts.

The average estimate of EPS for the current fiscal quarter for Host Hotels and Resorts Inc (NYSE:HST)stands at $0.50 while the EPS for the current year is fixed at $1.68 by 18.00 analysts

The next one year’s EPS estimate is set at 1.72 by 19.00 analysts while a year ago the analysts suggested the company’s EPS at $1.68. The analysts also projected the company’s long-term growth at 5.10% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Host Hotels and Resorts Inc (NYSE:HST)reported earnings of $0.41. The posted earnings topped the analyst’s consensus by $0.03 with the surprise factor of 7.90%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Host Hotels and Resorts Inc (NYSE:HST) traded up +0.89% during trading on Friday, hitting $17.12 . The stock had a trading volume of 7.3 M shares. The firm has a 50 day moving average of $15.74 and a 200-day moving average of $15.44. The stock has a market cap of $12.67B and a price-to-earnings ratio of 19.94. On Jul 16, 2015 the shares registered one year high at $21.40 and the one year low was seen on Jan 20, 2016.

On June 16, 2016 Host Hotels and Resorts Inc (NYSE:HST) will report financial results for the second quarter 2016 prior to market open on Friday, July 29, followed by a conference call at 10:00 a.m. Eastern Time (ET). Management will discuss the Company’s second quarter 2016 results and its business outlook for 2016.

Interested individuals are invited to listen to the call via telephone at (719) 457-1513.  It is recommended that participants call 10 minutes ahead of the scheduled start time to ensure proper connection.  A simultaneous webcast of the call will be available on the Company’s website at www.hosthotels.com. A replay of the call will be available Friday, July 29 at 1:00 p.m. ET until Friday, August 5, 2016 at 1:00 p.m. ET via telephone at (888) 203-1112, passcode number 1715410, or via webcast on the Company’s website through August 29, 2016.

Today’s Stock in Focus: Goldcorp (NYSE:GG)

The shares of Goldcorp Inc. (USA) (NYSE:GG)currently has mean rating of 2.7 while 8 analyst have recommended the shares as ‘BUY’ ,1 recommended as ‘OUTPERFORM’ and 9 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Goldcorp Inc. (USA) (NYSE:GG)is at $19.18 while the highest price target suggested by the analysts is $24.00 and low price target is $12.50. The mean price target is calculated keeping in view the consensus of 20 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 882.55M by 5 analysts. The means estimate of sales for the year ending Dec 16 is 3.89B by 17 analysts.

The average estimate of EPS for the current fiscal quarter for Goldcorp Inc. (USA) (NYSE:GG)stands at $0.04 while the EPS for the current year is fixed at $0.31 by 13.00 analysts

The next one year’s EPS estimate is set at 0.47 by 19.00 analysts while a year ago the analysts suggested the company’s EPS at $0.31. The analysts also projected the company’s long-term growth at -26.58% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Goldcorp Inc. (USA) (NYSE:GG)reported earnings of $0.09. The posted earnings topped the analyst’s consensus by $0.05 with the surprise factor of 125.00%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Goldcorp Inc. (USA) (NYSE:GG) traded down -2.49% during trading on Friday, hitting $18.01 . The stock had a trading volume of 7.1 M shares. The firm has a 50 day moving average of $17.80 and a 200-day moving average of $15.22. The stock has a market cap of $14.64B. On May 2, 2016 the shares registered one year high at $20.24 and the one year low was seen on Jan 21, 2016.

On June 20, 2016 Goldcorp Inc. (USA) (NYSE:GG) announces that it has entered into an agreement to acquire 10,884,880 common shares (“Shares”) of Independence Gold Corp. (“Independence Gold”) at a price of C$0.1333 per share for an aggregate purchase price of C$1,450,954.50 (the “Private Placement”).

The 10,884,880 Shares represent approximately 19.9% of the current issued and outstanding Shares of Independence Gold.

The Shares trade on the TSX Venture Exchange under the symbol “IGO”. The Shares will be issued from treasury pursuant to a donation arrangement private placement. Prior to the completion of the Private Placement, Goldcorp did not hold any Shares of Independence Gold. Following the completion of the Private Placement, Goldcorp will own 10,884,880 Shares representing approximately 19.9% of the issued and outstanding Shares of Independence Gold. The Shares are being acquired for investment purposes. Goldcorp will evaluate its investment in Independence Gold from time to time and may, based on such evaluation of market conditions and other circumstances, increase or decrease shareholdings as circumstances require.

This news release is being issued in accordance with National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. An early warning report respecting the Private Placement will be filed on System for Electronic Document Analysis and Review at www.sedar.com under Independence Gold’s issuer profile. In order to obtain a copy of the early warning report, please contact Randall Chatwin , Assistant General Counsel at Goldcorp, at telephone number: 604-696-3000.

Analyst’s Review to Watch: Annaly Capital Management (NYSE:NLY)

The shares of Annaly Capital Management, Inc. (NYSE:NLY)currently has mean rating of 2.9 while 3 analyst have recommended the shares as ‘BUY’ ,1 recommended as ‘OUTPERFORM’ and 9 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Annaly Capital Management, Inc. (NYSE:NLY)is at $10.98 while the highest price target suggested by the analysts is $13.00 and low price target is $8.00. The mean price target is calculated keeping in view the consensus of 13 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 278.03M by 5 analysts. The means estimate of sales for the year ending Dec 16 is 982.38M by 4 analysts.

The average estimate of EPS for the current fiscal quarter for Annaly Capital Management, Inc. (NYSE:NLY)stands at $0.30 while the EPS for the current year is fixed at $1.17 by 13.00 analysts

The next one year’s EPS estimate is set at 1.14 by 13.00 analysts while a year ago the analysts suggested the company’s EPS at $1.17. The analysts also projected the company’s long-term growth at -7.46% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Annaly Capital Management, Inc. (NYSE:NLY)reported earnings of $0.30. The posted earnings missed the analyst’s consensus by $0.00 with the surprise factor of 0.00%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Annaly Capital Management, Inc. (NYSE:NLY) traded up +0.75% during trading on Friday, hitting $10.80 . The stock had a trading volume of 7.0 M shares. The firm has a 50 day moving average of $10.78 and a 200-day moving average of $10.10. The stock has a market cap of $9.95B and a price-to-earnings ratio of 10760.00. On May 13, 2016 the shares registered one year high at $11.13 and the one year low was seen on Jan 20, 2016.

On June 16, 2016 Annaly Capital Management, Inc. (NYSE:NLY) declared the second quarter 2016 common stock cash dividend of $0.30 per common share. This dividend is payable July 29, 2016, to common shareholders of record on June 30, 2016. The ex-dividend date is June 28, 2016.

Dividends may be reinvested through the Company’s Dividend Reinvestment and Share Purchase Plan. Plan information may be obtained from the Plan Administrator, Computershare at 1-800-301-5234, at www.annaly.com, or by contacting the Company.

Annaly’s principal business objectives are to generate net income for distribution to its shareholders from its investments and capital preservation. Annaly is a Maryland corporation that has elected to be taxed as a real estate investment trust (“REIT”). Annaly is managed and advised by Annaly Management Company LLC.

Noticeable Stock: Merck & Co., Inc. (NYSE:MRK)

The shares of Merck & Co., Inc. (NYSE:MRK)currently has mean rating of 2.5 while 7 analyst have recommended the shares as ‘BUY’ ,2 recommended as ‘OUTPERFORM’ and 13 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Merck & Co., Inc. (NYSE:MRK)is at $61.60 while the highest price target suggested by the analysts is $80.04 and low price target is $53.00. The mean price target is calculated keeping in view the consensus of 20 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 9.79B by 13 analysts. The means estimate of sales for the year ending Dec 16 is 39.52B by 16 analysts.

The average estimate of EPS for the current fiscal quarter for Merck & Co., Inc. (NYSE:MRK)stands at $0.91 while the EPS for the current year is fixed at $3.72 by 16.00 analysts

The next one year’s EPS estimate is set at 3.76 by 22.00 analysts while a year ago the analysts suggested the company’s EPS at $3.72. The analysts also projected the company’s long-term growth at 3.35% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Merck & Co., Inc. (NYSE:MRK)reported earnings of $0.89. The posted earnings topped the analyst’s consensus by $0.04 with the surprise factor of 4.70%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Merck & Co., Inc. (NYSE:MRK) traded up +1.12% during trading on Friday, hitting $57.68 . The stock had a trading volume of 7.0 M shares. The firm has a 50 day moving average of $55.80 and a 200-day moving average of $53.41. The stock has a market cap of $159.66B and a price-to-earnings ratio of 35.36. On Aug 19, 2015 the shares registered one year high at $60.07 and the one year low was seen on Aug 24, 2015.

Merck & Co., Inc. provides health care solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also provides neuromuscular blocking agents for use in surgery; anti-bacterial products for skin and skin structure infections; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it provides antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics for the treatment of C. difficile, and vaccines against bacterial and viral disease in fish. Additionally, the company offers companion animal products, such as ointments for acute and chronic otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Noticeable Stock: Gerdau SA (NYSE:GGB)

The shares of Gerdau SA (ADR) (NYSE:GGB)currently has mean rating of 2.6 while 3 analyst have recommended the shares as ‘BUY’ ,0 recommended as ‘OUTPERFORM’ and 4 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Gerdau SA (ADR) (NYSE:GGB)is at $5.60 while the highest price target suggested by the analysts is $6.95 and low price target is $4.41. The mean price target is calculated keeping in view the consensus of 6 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 11.68B by 1 analysts. The means estimate of sales for the year ending Dec 16 is 45.19B by 4 analysts.

The average estimate of EPS for the current fiscal quarter for Gerdau SA (ADR) (NYSE:GGB)stands at $-0.02 while the EPS for the current year is fixed at $0.13 by 2.00 analysts

The next one year’s EPS estimate is set at 0.23 by 5.00 analysts while a year ago the analysts suggested the company’s EPS at $0.13. The analysts also projected the company’s long-term growth at -37,628.50% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Gerdau SA (ADR) (NYSE:GGB)reported earnings of $0.01. The posted earnings missed the analyst’s consensus by $-0.02 with the surprise factor of -66.70%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Gerdau SA (ADR) (NYSE:GGB) traded up +9.41% during trading on Friday, hitting $1.86 . The stock had a trading volume of 6.5 M shares. The firm has a 50 day moving average of $1.74 and a 200-day moving average of $1.46. The stock has a market cap of $3.14B. On Jun 30, 2015 the shares registered one year high at $2.54 and the one year low was seen on Jan 21, 2016.

Gerdau S.A. produces and commercializes steel products worldwide. The company operates through Brazil Business Operation, North America Business Operation, South America Business Operation, and Special Steel Business Operation segments. It offers semi-finished products, such as billets, blooms, and slabs; common long rolled products, including rebars, merchant bars, and profiles that are used by the construction and manufacturing industries; and drawn products consisting of barbed and barbless fence wire, galvanized wire, fences, concrete reinforcing wire mesh, nails, and clamps, as well as iron ore. It also produces special steel products used in automotive components, machinery, road and agricultural parts, mining equipment, tools, rail components, and maritime mooring. In addition, it provides flat products, such as hot- and cold-rolled steel coils, heavy plates, and structural profiles. The company sells its products through independent distributors, direct sales from the mills, and its retail network. The company was founded in 1901 and is based in Porto Alegre, Brazil.

Stock Under Analyst’s Radar: Johnson & Johnson (NYSE:JNJ)

The shares of Johnson & Johnson (NYSE:JNJ)currently has mean rating of 2.4 while 7 analyst have recommended the shares as ‘BUY’ ,3 recommended as ‘OUTPERFORM’ and 12 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Johnson & Johnson (NYSE:JNJ)is at $117.89 while the highest price target suggested by the analysts is $126.00 and low price target is $105.00. The mean price target is calculated keeping in view the consensus of 18 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 17.98B by 16 analysts. The means estimate of sales for the year ending Dec 16 is 71.76B by 21 analysts.

The average estimate of EPS for the current fiscal quarter for Johnson & Johnson (NYSE:JNJ)stands at $1.69 while the EPS for the current year is fixed at $6.61 by 19.00 analysts

The next one year’s EPS estimate is set at 7.00 by 22.00 analysts while a year ago the analysts suggested the company’s EPS at $6.61. The analysts also projected the company’s long-term growth at 6.00% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Johnson & Johnson (NYSE:JNJ)reported earnings of $1.68. The posted earnings topped the analyst’s consensus by $0.03 with the surprise factor of 1.80%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Johnson & Johnson (NYSE:JNJ) traded up +0.79% during trading on Friday, hitting $117.38 . The stock had a trading volume of 6.8 M shares. The firm has a 50 day moving average of $114.65 and a 200-day moving average of $107.62. The stock has a market cap of $322.87B and a price-to-earnings ratio of 21.39. On Jun 15, 2016 the shares registered one year high at $117.74 and the one year low was seen on Aug 24, 2015.

On June 22, 2016 Johnson & Johnson (NYSE:JNJ) announced that Louise Mehrotra, Vice President of Investor Relations for Johnson & Johnson, will retire in January 2017, after a transition period with her successor. Louise first joined the Johnson & Johnson Family of Companies in 1980, and has led Investor Relations for more than 10 years.

“Louise has been a constant advocate for transparency and credibility in our financial communications, a trusted advisor to company management, and her commitment to excellence has led to the development of a best-in-class IR team,” said Dominic J. Caruso, Executive Vice President, Chief Financial Officer of Johnson & Johnson. “We sincerely thank her for more than 35 years of service, and for her leadership in helping develop a strong and diverse Finance organization at Johnson & Johnson.”

Joseph Wolk will replace Mehrotra as Vice President, Investor Relations, effective August 1. Wolk will continue to report to Dominic Caruso.

“Joe is a proven leader in our Finance organization, and we are confident he will continue our commitment to transparent and credible engagement with the investment community. His cross-sector expertise, prudent financial management and focus on talent development will ensure the investor relations function at Johnson & Johnson remains best-in-class,” said Caruso.

Wolk was previously Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson, where he provided finance leadership, supporting Worldwide Chairman, Pharmaceuticals Joaquin Duato, and Chief Scientific Officer Paul Stoffels, as a member of the Pharmaceuticals Group Operating Committee. Prior to that role, he held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain, and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc., as well as U.S. Pricing Strategy and Compliance. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization.

Prior to joining Johnson & Johnson, Wolk held multiple positions of increasing responsibility at Ametek, Inc. He holds a Bachelor of Science degree in Finance from St. Joseph’s University, where he currently serves on the Haub School of Business Board of Visitors, and he also holds a Juris Doctor degree from Temple University School of Law and is a Certified Public Accountant.